Incidence, management, and outcome of posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
Molmenti
E P
EP
Baylor University Medical Center, Children's Medical Center of Dallas, Dallas, Texas, USA.
Nagata
D
D
Roden
J
J
Squires
R
R
Molmenti
H
H
Casey
D
D
Fasola
C
C
Lopez
M J
MJ
Winick
N
N
McPhail
W
W
D'Amico
L
L
Goldstein
R
R
Levy
M
M
Fasola
C
C
Andersen
J
J
Klintmalm
G
G
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D007223:Infant; D016031:Liver Transplantation; D008232:Lymphoproliferative Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D008297:Male; D011183:Postoperative Complications / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D016559:Tacrolimus / Q000627:therapeutic use; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus